Skip to content
Menu

Novavax, Inc. NVAX

Full chart Compare
Set alert

Price alert · NVAX

All alert types
7.96 USD 0.00 (+0.00%)

Regular-session close

7.99 +0.03 +0.33%

After hours · Nov 18, 7:59 PM ET

7.85 Day range 8.32
6.20 52-week range 13.39
YTD
+18.45%
1 year
+21.16%

Revenue & Expenses

Revenue by
Revenue Profit Costs
Gross Profit$1.05BCost of Revenue$71.14MNet Income$440.30MSelling, General & Admin$150.35MResearch & Development$336.82MOther Operating Expenses$1.90MInterest Expense$22.55MOther Expenses$98.56MIncome Tax$1.86MRevenue$1.12BRest of North America$575.67MUnited States$405.61MRest of the World$126.46MEurope$15.74M

Latest period ending Dec 31, 2025 · select a line to chart its full history

NVAX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.12B682.16M983.71M1.98B1.15B
1.05B479.42M639.94M1.08B1.15B
452.80M-248.93M-566.51M-644.74M-1.69B
440.30M-187.50M-545.06M-657.94M-1.74B
2.72-1.23-5.41-8.42-23.44
NVAX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
251.51M540.86M578.93M1.35B1.53B
1.18B1.56B1.80B2.26B2.58B
1.30B2.18B2.51B2.89B2.93B
248.81M230.42M229.08M549.78M453.99M
-127.75M-623.84M-716.93M-634.08M-351.67M
NVAX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-244.63M-87.26M-713.97M-415.94M322.95M
-78.27M-204.04M-58.81M-92.98M100.15M
27.74M260.58M4.47M324.99M461.71M
-6.39M-14.64M-58.81M-92.98M-57.49M
-289.24M-38.52M-765.03M-179.41M879.52M